173 related articles for article (PubMed ID: 15308355)
1. CD40 antibody as an adjuvant induces enhanced T cell responses.
Carlring J; Barr TA; McCormick AL; Heath AW
Vaccine; 2004 Sep; 22(25-26):3323-8. PubMed ID: 15308355
[TBL] [Abstract][Full Text] [Related]
2. CD40 antibody as a potent immunological adjuvant: CD40 antibody provides the CD40 signal to B cells, but does not substitute for T cell help in responses to TD antigens.
Barr TA; Carlring J; Heath AW
Vaccine; 2005 May; 23(26):3477-82. PubMed ID: 15837371
[TBL] [Abstract][Full Text] [Related]
3. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
4. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
[TBL] [Abstract][Full Text] [Related]
5. CD40-expressing plasmid induces anti-CD40 antibody and enhances immune responses to DNA vaccination.
Xu H; Zhao G; Huang X; Ding Z; Wang J; Wang X; Cheng Y; Kang Y; Wang B
J Gene Med; 2010 Jan; 12(1):97-106. PubMed ID: 19950201
[TBL] [Abstract][Full Text] [Related]
6. Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN.
Ahonen CL; Doxsee CL; McGurran SM; Riter TR; Wade WF; Barth RJ; Vasilakos JP; Noelle RJ; Kedl RM
J Exp Med; 2004 Mar; 199(6):775-84. PubMed ID: 15007094
[TBL] [Abstract][Full Text] [Related]
7. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.
Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H
Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497
[TBL] [Abstract][Full Text] [Related]
8. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner.
Rodríguez-Pinto D; Moreno J
Eur J Immunol; 2005 Apr; 35(4):1097-105. PubMed ID: 15756646
[TBL] [Abstract][Full Text] [Related]
9. Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.
Ohmura-Hoshino M; Yamamoto M; Yuki Y; Takeda Y; Kiyono H
Vaccine; 2004 Sep; 22(27-28):3751-61. PubMed ID: 15315856
[TBL] [Abstract][Full Text] [Related]
10. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
11. Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120.
McCormick AL; Thomas MS; Heath AW
J Infect Dis; 2001 Dec; 184(11):1423-30. PubMed ID: 11709784
[TBL] [Abstract][Full Text] [Related]
12. A novel method for enhancement of T independent responses.
Dullforce P; Sutton D; Heath AW
Dev Biol Stand; 1998; 92():195-8. PubMed ID: 9554275
[TBL] [Abstract][Full Text] [Related]
13. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help.
French RR; Chan HT; Tutt AL; Glennie MJ
Nat Med; 1999 May; 5(5):548-53. PubMed ID: 10229232
[TBL] [Abstract][Full Text] [Related]
14. Additive effects of CpG ODN and R-848 as adjuvants on augmenting immune responses to HBsAg vaccination.
Ma R; Du JL; Huang J; Wu CY
Biochem Biophys Res Commun; 2007 Sep; 361(2):537-42. PubMed ID: 17662694
[TBL] [Abstract][Full Text] [Related]
15. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
Nyström-Asklin J; Adamsson J; Harandi AM
Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone sulphate enhances IgG and Interferon-gamma production during immunization to tuberculosis in young but not aged mice.
Ribeiro F; Lopes RP; Nunes CP; Maito F; Bonorino C; Bauer ME
Biogerontology; 2007 Apr; 8(2):209-20. PubMed ID: 17082909
[TBL] [Abstract][Full Text] [Related]
17. Ethanol consumption modifies dendritic cell antigen presentation in mice.
Heinz R; Waltenbaugh C
Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of cell-mediated immune functions by encapsulated and surface-linked liposomal antigens.
Fortin A; Shahum E; Krzystyniak K; Thérien HM
Cell Immunol; 1996 May; 169(2):208-17. PubMed ID: 8620548
[TBL] [Abstract][Full Text] [Related]
20. CD40 monoclonal antibody activation of antigen-presenting cells improves therapeutic efficacy of tumor-specific T cells.
Bergstrom RT; Silverman DA; Chambers K; Kim JA
Otolaryngol Head Neck Surg; 2004 Jan; 130(1):94-103. PubMed ID: 14726917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
